Metraipolis › archive › dc_ca420d714357

GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection — Europe PMC PMID:42416049

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42416049
DOI
10.3389/fimmu.2026.1839620
License (as archived)
solo-consultazione
Archived
2026-10-19T05:56:50.362Z
SHA-256 of the archived text
33cf244b386b7e8ff94cabfac187a205e5c28da03dd7f6d92be12ffff98fa219
Stable URL of this page
https://metraipolis.com/documento/dc_ca420d714357

How to cite

GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection — Europe PMC PMID:42416049 — Europe PMC (en), https://europepmc.org/article/MED/42416049 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca420d714357 (Metraipolis archive dc_ca420d714357, sha256 33cf244b386b7e8ff94cabfac187a205e5c28da03dd7f6d92be12ffff98fa219)
BibTeX
@misc{dcca420d714357,
  title = {GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection — Europe PMC PMID:42416049},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42416049},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca420d714357; sha256 33cf244b386b7e8ff94cabfac187a205e5c28da03dd7f6d92be12ffff98fa219},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42416049. Agents can read the archived copy with the MCP tool read_document.